Who owns Evommune, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of EVMN from SEC Form 13F filings across 104 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 104 institutions disclosed 33.5M shares of Evommune, Inc. worth $276.8M — about 92.2% of shares outstanding; the largest disclosed holder is EQT Fund Management S.a r.l.. Source: SEC Form 13F filings, parsed by EvidInvest.
104
13F holders
$276.8M
value, 2026 filers
92.2%
of shares outstanding (33.5M sh)
25
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of EVMN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | EQT Fund Management S.a r.l. | 5.3M | $43.7M | 4.6% | 14.6% | 0.0% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 3.5M | $28.9M | 0.3% | 9.6% | 0.0% |
| 3 | Point72 Asset Management, L.P. | 2.4M | $20.1M | 0.0% | 6.7% | +69.6% |
| 4 | Pivotal bioVenture Partners Investment Advisor LLC | 1.9M | $15.9M | 6.3% | 5.3% | 0.0% |
| 5 | Nan Fung Group Holdings Ltd | 1.4M | $11.9M | 8.0% | 4% | 0.0% |
| 6 | Defilade Capital Management, L.P. | 1.4M | $11.8M | 2.0% | 3.9% | +80.4% |
| 7 | Vestal Point Capital, LP | 1.3M | $10.3M | 0.3% | 3.4% | +25.0% |
| 8 | BAKER BROS. ADVISORS LP | 1.2M | $10.2M | 0.0% | 3.4% | +45.7% |
| 9 | Kynam Capital Management, LPNEW | 1.2M | $9.9M | 0.5% | 3.3% | new |
| 10 | BlackRock, Inc. | 1.2M | $9.5M | 0.0% | 3.2% | +30.2% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 1.0M | $8.3M | 0.0% | 2.8% | +13.9% |
| 12 | PRICE T ROWE ASSOCIATES INC /MD/ | 851,866 | $7.0M | 0.0% | 2.3% | -56.1% |
| 13 | MILLENNIUM MANAGEMENT LLCNEW | 847,296 | $7.0M | 0.0% | 2.3% | new |
| 14 | AMERICAN CENTURY COMPANIES INC | 762,340 | $6.3M | 0.0% | 2.1% | +1.0% |
| 15 | Qube Research & Technologies Ltd | 684,713 | $5.7M | 0.0% | 1.9% | +2173.7% |
| 16 | SILVERARC CAPITAL MANAGEMENT, LLCNEW | 594,027 | $4.9M | 0.6% | 1.6% | new |
| 17 | BARCLAYS PLC | 526,560 | $4.3M | 0.0% | 1.4% | +194.6% |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 467,271 | $3.9M | 0.0% | 1.3% | +54.8% |
| 19 | Velan Capital Investment Management LP | 456,255 | $3.8M | 3.6% | 1.3% | +1.1% |
| 20 | SPHERA FUNDS MANAGEMENT LTD. | 390,632 | $3.2M | 0.5% | 1.1% | +1626.0% |
| 21 | CITADEL ADVISORS LLC | 379,729 | $3.1M | 0.0% | 1% | +3440.9% |
| 22 | JANE STREET GROUP, LLC | 330,031 | $2.7M | 0.0% | 0.9% | +42.0% |
| 23 | GREAT POINT PARTNERS LLC | 325,000 | $2.7M | 0.6% | 0.9% | 0.0% |
| 24 | GOLDMAN SACHS GROUP INC | 301,400 | $2.5M | 0.0% | 0.8% | +56.2% |
| 25 | Trexquant Investment LPNEW | 284,954 | $2.4M | 0.0% | 0.8% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.